Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 481-500 of 1,550 trials

Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System

NCT03214601

The purpose of this study is to conduct an early clinical evaluation of the Relay Branch System, which will provide initial insight into the clinical safety and function of the device. This Early Feasibility Study (EFS) will assess the safety and effectiveness of the device at the index procedure and at 30-day follow-up. The study will evaluate the delivery and deployment of the device, patency of branches and branch vessels, and exclusion of the aortic pathology. The data will help determine if modifications need to be made to the device, the procedural steps, operator technique, or the indications for use.

Thoracic Aorta AneurysmAneurysm, RupturedAortic Aneurysm

Bolton Medical30 participantsStarted Dec 2017

Los Angeles, California, United States • Gainesville, Florida, United States • Atlanta, Georgia, United States +9 more locations

COMPLETEDPHASE2< 1 mile

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

NCT03867097

This is a Phase 2, multicenter, double-blind, randomized, placebo-controlled study to evaluate the effect of iloprost on the symptomatic relief of Raynaud's Phenomenon attacks in subjects with symptomatic Raynaud's Phenomenon secondary to Systemic Sclerosis.

Raynaud Phenomenon Secondary to Systemic Sclerosis

Civi Biopharma, Inc.34 participantsStarted Mar 2019

Phoenix, Arizona, United States • Los Angeles, California, United States • Palo Alto, California, United States +13 more locations

Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

Rheumatoid Arthritis Trials in Other Cities

Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring

MAGIC Ruxolitinib for aGVHD

Eyelid Androgen Treatment in Dry Eye

Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz

Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults

RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD

StimRouter Registry Clinical Protocol

Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics

The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)

Modifiers of Disease Severity in Cerebral Cavernous Malformations

Tornier Shoulder Outcomes Study to Examine Safety and Functional Outcomes in Shoulder Arthroplasty and Fracture Patients

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Other Conditions in Los Angeles